Intellia Therapeutics, Inc.

CIK 1652130 · 727 filings in 42 form types · 2015-09-03 to 2026-11-20 · NTLA

FiledFormCategory8-K items / descriptionAccession
2026-11-20 S-3ASR Registrations and prospectuses 0001193125-26-470525
2026-11-13 8-K/A Current reports 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits 0001193125-26-460948
2026-11-12 8-K Current reports 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits 0001193125-26-458422
2026-11-10 SCHEDULE 13G Ownership 0000093751-26-000674
2026-11-05 10-Q Financial reports 10-Q 0001193125-26-449862
2026-11-05 8-K Current reports 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits 0001193125-26-448673
2026-11-03 4 Ownership 0001193125-26-445417
2026-11-02 144 Ownership 0001969223-26-001116
2026-10-28 4 Ownership 0001193125-26-436131
2026-10-28 3 Ownership 0001193125-26-436123
2026-10-06 4 Ownership 0001193125-26-415541
2026-10-05 144 Ownership 0001950047-26-010054
2026-09-08 8-K Current reports 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits 0001193125-26-385194
2026-09-04 8-K Current reports 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits 0001193125-26-383645
2026-08-24 4 Ownership 0001193125-26-363567
2026-08-20 144 Ownership 0001969223-26-000938
2026-08-07 SCHEDULE 13G Ownership 0000093751-26-000484
2026-08-06 10-Q Financial reports 10-Q 0001193125-26-337952
2026-08-06 8-K Current reports 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits 0001193125-26-336772
2026-07-24 4 Ownership 0001193125-26-316279
2026-07-06 4 Ownership 0002019493-26-000002
2026-07-06 4 Ownership 0001821530-26-000002
2026-07-02 144 Ownership 0001950047-26-006836
2026-06-15 8-K Current reports 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits 0001193125-26-270358
2026-06-10 4 Ownership 0001756929-26-000002
2026-06-10 4 Ownership 0001563572-26-000001
2026-06-10 4 Ownership 0001545794-26-000001
2026-06-10 4 Ownership 0001193125-26-266241
2026-06-10 4 Ownership 0001193125-26-266236
2026-06-10 4 Ownership 0001193125-26-266233
2026-06-10 4 Ownership 0001193125-26-266230
2026-06-10 8-K Current reports 5.07 Submission of Matters to a Vote of Security Holders 0001193125-26-265934
2026-05-11 10-Q Financial reports 10-Q 0001193125-26-215740
2026-05-11 8-K Current reports 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits 0001193125-26-215721
2026-04-30 SCHEDULE 13G Ownership 0002100119-26-000581
2026-04-30 8-K Current reports 1.01 Entry into a Material Definitive Agreement; 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits 0001193125-26-197489
2026-04-30 ARS Financial reports 0001193125-26-197422
2026-04-30 DEFA14A Proxies 0001193125-26-197355
2026-04-30 DEF 14A Proxies 0001193125-26-197283
2026-04-29 SCHEDULE 13G Ownership 0002100121-26-000395
2026-04-29 424B5 Registrations and prospectuses 0001193125-26-192361
2026-04-27 424B5 Registrations and prospectuses 0001193125-26-182419
2026-04-27 8-K Current reports 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits 0001193125-26-179401
2026-04-10 8-K Current reports 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 9.01 Financial Statements and Exhibits 0001193125-26-151300
2026-03-27 SCHEDULE 13G/A Ownership 0000102909-26-001517
2026-03-03 4 Ownership 0001193125-26-088269
2026-03-03 4 Ownership 0001193125-26-088260
2026-03-03 4 Ownership 0001193125-26-088258
2026-03-03 4 Ownership 0001193125-26-088254
2026-03-03 4 Ownership 0001193125-26-088251